Yoshikazu Sasaki

No ORCID on file · 2 papers in corpus
2017
Biomedical reports ·doi:10.3892/br.2017.990

Inhibitors of poly(ADP-ribose) polymerase (PARP) are new types of personalized treatment of relapsed platinum-sensitive ovarian cancer harboring BRCA1/2 mutations. Ovarian clear cell cancer (CCC), a subset of ovarian cancer, often appears a…

other 2013
Oncology letters ·doi:10.3892/ol.2013.1550

Endometriosis-associated ovarian cancers demonstrate substantial morphological and genetic diversity. The transcription factor, hepatocyte nuclear factor (HNF)-1β, may be one of several key genes involved in the identity of ovarian clear ce…